Delivery Order SPE2DB20D1100-SPE2DB24FD4P5

Award Date 8/26/24
Potential Completion Date 8/27/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $17,293.59, is for the delivery of OPZELURA 1.5% Cream in 60 gram packaging. The order is a firm fixed-price contract with a completion date of July 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a $1,793.62 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The order is for the pharmaceutical product OPZELURA 1.5% CREAM 60GM and has a completion date of July 29, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the federal government, supporting various defense and civilian agencies. This delivery order is issued under a larger Indefinite Delivery...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,330.79, is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product. The contract has a performance period through May 12, 2023 and is a Firm Fixed Price type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $1,395.71 Firm Fixed Price contract is for the supply of OPZELURA 1.5% Cream (60g), a prescription dermatological product. The contract has an ultimate completion date of July 31, 2024. AmerisourceBergen is a long-standing supplier to the DLA Troop Support Medical program, providing a wide range of pharmaceutical and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,039.11 firm-fixed-price delivery order is for the supply of OPZELURA 1.5% cream, a pharmaceutical product, to support the DLA's medical requirements. The contract has an ultimate completion date of July 11, 2024 and was awarded on July 10, 2024. This award is associated with Amerisourcebergen's $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,451.14 firm fixed-price delivery order is for the pharmaceutical product OPZELURA 1.5% CREAM 60GM. The contract has an ultimate completion date of March 26, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,780.38 Firm Fixed Price Delivery Order is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product, with a completion date of November 15, 2023. This award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product OPZELURA 1.5% CREAM 60GM. The contract has a ceiling value of $2,478.93 and was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), on June 24, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 25, 2024. This award is a task...
This federal contract award, valued at $1,623.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% Cream, a 60-gram pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of November 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of the pharmaceutical product OPZELURA 1.5% Cream in 60 gram quantities. The $1,342.69 firm fixed-price delivery order was issued by the Defense agency Medical Supply Chain (DLA Troop Support Medical) and has an ultimate completion date of April 17, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD4P5
    Delivery Order

This is a delivery order award to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) for the pharmaceutical product OPZELURA 1.5% Cream, 60 grams. The firm-fixed-price contract is valued at $11,433.56 with an ultimate completion date of August 27, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a wide range of medical commodities to support military treatment programs and facilities worldwide. This contract award does not have a set-aside designation.

Generated 11/25/24, 9:15 AM